ID

28078

Descripción

Investigating Intracellular and Plasma Imatinib Levels in Chronic Myeloid Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00947830

Link

https://clinicaltrials.gov/show/NCT00947830

Palabras clave

Versiones (1)
  1. 15/12/17 15/12/17 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

15 de diciembre de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Chronic Myeloid Leukemia NCT00947830

Inglés

Eligibility Chronic Myeloid Leukemia NCT00947830

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients must have a diagnosis of chronic myeloid leukemia in chronic phase (as defined in appendix a) within four weeks of study registration based on bone marrow aspirate and peripheral blood counts. - patients must have confirmation of the philadelphia chromosome or variants by cytogenetics, or fish, or positive test for bcr-abl by pcr. patients with additional chromosomal abnormalities in addition to the philadelphia chromosome are eligible.
Descripción

Myeloid Leukemia Chronic-Phase Bone marrow aspirate examination | Myeloid Leukemia Chronic-Phase Blood Count Peripheral blood | Philadelphia chromosome positive Cytogenetic Analysis | Philadelphia chromosome positive FISH | Philadelphia Chromosome Variant Positive Cytogenetic Analysis | Philadelphia Chromosome Variant Positive FISH | BCR-ABL Positive Polymerase Chain Reaction | Chromosome Aberrations Additional

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0023474
UMLS CUI [1,2]
C1271729
UMLS CUI [2,1]
C0023474
UMLS CUI [2,2]
C0005771
UMLS CUI [2,3]
C0229664
UMLS CUI [3,1]
C0856536
UMLS CUI [3,2]
C0752095
UMLS CUI [4,1]
C0856536
UMLS CUI [4,2]
C0162789
UMLS CUI [5,1]
C0031526
UMLS CUI [5,2]
C0205419
UMLS CUI [5,3]
C1514241
UMLS CUI [5,4]
C0752095
UMLS CUI [6,1]
C0031526
UMLS CUI [6,2]
C0205419
UMLS CUI [6,3]
C1514241
UMLS CUI [6,4]
C0162789
UMLS CUI [7,1]
C1835417
UMLS CUI [7,2]
C1514241
UMLS CUI [7,3]
C0032520
UMLS CUI [8,1]
C0008625
UMLS CUI [8,2]
C1524062
age >18 years.
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
ecog performance status <2. (appendix b)
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
patients must have normal organ function as defined below:
Descripción

Organ function

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0678852
total bilirubin < 1.5 x institutional upper limit of normal (uln)
Descripción

Serum total bilirubin measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1278039
ast and/or alt < 2.5 x institutional upper limit of normal (uln)
Descripción

Aspartate aminotransferase measurement | Alanine aminotransferase measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0201899
UMLS CUI [2]
C0201836
eligibility of patients receiving any medications or substances known to affect or determined following review of their case by the principal investigator.
Descripción

Pharmaceutical Preparations Affecting Review of Case

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0699752
UMLS CUI [1,4]
C0868928
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients may not be receiving any other investigational agents.
Descripción

Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0013230
patients may not have received prior treatment with imatinib.
Descripción

imatinib

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0935989
uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.
Descripción

Comorbidity Uncontrolled | Communicable Disease | Symptomatic congestive heart failure | Angina, Unstable | Cardiac Arrhythmia | Mental disorders Protocol Compliance Limited | Social situation Protocol Compliance Limited

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205318
UMLS CUI [2]
C0009450
UMLS CUI [3]
C0742758
UMLS CUI [4]
C0002965
UMLS CUI [5]
C0003811
UMLS CUI [6,1]
C0004936
UMLS CUI [6,2]
C0525058
UMLS CUI [6,3]
C0439801
UMLS CUI [7,1]
C0748872
UMLS CUI [7,2]
C0525058
UMLS CUI [7,3]
C0439801
pregnant or nursing women are excluded from this study because imatinib has potential teratogenic effects and excretion in breast milk is unknown.
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
no prior malignancies except for: adequately treated non-melanoma skin cancer, cervical carcinoma-in-situ, adequately treated stage i or ii cancer from which patient is in complete remission, or any other cancer from which patient has been disease free for 5 years.
Descripción

Malignant Neoplasms | Exception Skin carcinoma Treated | Exception Carcinoma in situ of uterine cervix Treated | Exception Malignant Neoplasm TNM clinical staging Treated | Exception Malignant Neoplasm In complete remission | Exception Cancer Other Disease Free of

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0699893
UMLS CUI [2,3]
C1522326
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0851140
UMLS CUI [3,3]
C1522326
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0006826
UMLS CUI [4,3]
C3258246
UMLS CUI [4,4]
C1522326
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C0006826
UMLS CUI [5,3]
C0677874
UMLS CUI [6,1]
C1705847
UMLS CUI [6,2]
C1707251
UMLS CUI [6,3]
C0012634
UMLS CUI [6,4]
C0332296
Volver a la parte superior de la página

Similar models

Eligibility Chronic Myeloid Leukemia NCT00947830

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Myeloid Leukemia Chronic-Phase Bone marrow aspirate examination | Myeloid Leukemia Chronic-Phase Blood Count Peripheral blood | Philadelphia chromosome positive Cytogenetic Analysis | Philadelphia chromosome positive FISH | Philadelphia Chromosome Variant Positive Cytogenetic Analysis | Philadelphia Chromosome Variant Positive FISH | BCR-ABL Positive Polymerase Chain Reaction | Chromosome Aberrations Additional
Item
patients must have a diagnosis of chronic myeloid leukemia in chronic phase (as defined in appendix a) within four weeks of study registration based on bone marrow aspirate and peripheral blood counts. - patients must have confirmation of the philadelphia chromosome or variants by cytogenetics, or fish, or positive test for bcr-abl by pcr. patients with additional chromosomal abnormalities in addition to the philadelphia chromosome are eligible.
boolean
C0023474 (UMLS CUI [1,1])
C1271729 (UMLS CUI [1,2])
C0023474 (UMLS CUI [2,1])
C0005771 (UMLS CUI [2,2])
C0229664 (UMLS CUI [2,3])
C0856536 (UMLS CUI [3,1])
C0752095 (UMLS CUI [3,2])
C0856536 (UMLS CUI [4,1])
C0162789 (UMLS CUI [4,2])
C0031526 (UMLS CUI [5,1])
C0205419 (UMLS CUI [5,2])
C1514241 (UMLS CUI [5,3])
C0752095 (UMLS CUI [5,4])
C0031526 (UMLS CUI [6,1])
C0205419 (UMLS CUI [6,2])
C1514241 (UMLS CUI [6,3])
C0162789 (UMLS CUI [6,4])
C1835417 (UMLS CUI [7,1])
C1514241 (UMLS CUI [7,2])
C0032520 (UMLS CUI [7,3])
C0008625 (UMLS CUI [8,1])
C1524062 (UMLS CUI [8,2])
Age
Item
age >18 years.
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status <2. (appendix b)
boolean
C1520224 (UMLS CUI [1])
Organ function
Item
patients must have normal organ function as defined below:
boolean
C0678852 (UMLS CUI [1])
Serum total bilirubin measurement
Item
total bilirubin < 1.5 x institutional upper limit of normal (uln)
boolean
C1278039 (UMLS CUI [1])
Aspartate aminotransferase measurement | Alanine aminotransferase measurement
Item
ast and/or alt < 2.5 x institutional upper limit of normal (uln)
boolean
C0201899 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
Pharmaceutical Preparations Affecting Review of Case
Item
eligibility of patients receiving any medications or substances known to affect or determined following review of their case by the principal investigator.
boolean
C0013227 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0699752 (UMLS CUI [1,3])
C0868928 (UMLS CUI [1,4])
Item Group
C0680251 (UMLS CUI)
Investigational New Drugs
Item
patients may not be receiving any other investigational agents.
boolean
C0013230 (UMLS CUI [1])
imatinib
Item
patients may not have received prior treatment with imatinib.
boolean
C0935989 (UMLS CUI [1])
Comorbidity Uncontrolled | Communicable Disease | Symptomatic congestive heart failure | Angina, Unstable | Cardiac Arrhythmia | Mental disorders Protocol Compliance Limited | Social situation Protocol Compliance Limited
Item
uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.
boolean
C0009488 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0009450 (UMLS CUI [2])
C0742758 (UMLS CUI [3])
C0002965 (UMLS CUI [4])
C0003811 (UMLS CUI [5])
C0004936 (UMLS CUI [6,1])
C0525058 (UMLS CUI [6,2])
C0439801 (UMLS CUI [6,3])
C0748872 (UMLS CUI [7,1])
C0525058 (UMLS CUI [7,2])
C0439801 (UMLS CUI [7,3])
Pregnancy | Breast Feeding
Item
pregnant or nursing women are excluded from this study because imatinib has potential teratogenic effects and excretion in breast milk is unknown.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Malignant Neoplasms | Exception Skin carcinoma Treated | Exception Carcinoma in situ of uterine cervix Treated | Exception Malignant Neoplasm TNM clinical staging Treated | Exception Malignant Neoplasm In complete remission | Exception Cancer Other Disease Free of
Item
no prior malignancies except for: adequately treated non-melanoma skin cancer, cervical carcinoma-in-situ, adequately treated stage i or ii cancer from which patient is in complete remission, or any other cancer from which patient has been disease free for 5 years.
boolean
C0006826 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0699893 (UMLS CUI [2,2])
C1522326 (UMLS CUI [2,3])
C1705847 (UMLS CUI [3,1])
C0851140 (UMLS CUI [3,2])
C1522326 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C0006826 (UMLS CUI [4,2])
C3258246 (UMLS CUI [4,3])
C1522326 (UMLS CUI [4,4])
C1705847 (UMLS CUI [5,1])
C0006826 (UMLS CUI [5,2])
C0677874 (UMLS CUI [5,3])
C1705847 (UMLS CUI [6,1])
C1707251 (UMLS CUI [6,2])
C0012634 (UMLS CUI [6,3])
C0332296 (UMLS CUI [6,4])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial